15.69000 USD
0.16
1.01%
Last update Dec 15, 3:59 PM EST
Market closed
Day range
15.63000
16.069000
Previous close
15.85000
Open
15.95000
Access this stock data via API
Subscribe
Aurinia Pharmaceuticals Inc.
15.69
0.16
1.01%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 235.1M 175.5M 134.0M 45.6M
Cost of revenue 28.2M 14.1M 5.7M 1.1M
Gross profit 206.9M 161.4M 128.4M 44.5M
Operating expense
Research & development 20.8M 49.6M 45.0M 51.1M
Selling general and admin 172.0M 195.0M 196.4M 173.5M
Other operating expenses -4.3M 8.4M -1.5M 574K
Operating income 18.4M -91.7M -111.5M -180.7M
Non operating interest income
Income 17.0M 17.0M 5.1M 529K
Expense 4.8M 2.8M 0 0
Other income expense -23.1M
Pretax income 7.4M -77.5M -106.4M -180.2M
Tax provision 1.7M 551K 1.8M 760K
Net income 5.8M -78.0M -108.2M -181.0M
Basic EPS 0.0 -0.5 -0.8 -1.4
Diluted EPS 0.0 -0.5 -0.8 -1.4
Basic average shares 143.1M 143.2M 141.9M 129.4M
Diluted average shares 143.1M 143.2M 141.9M 129.4M
EBITDA 54.8M -63.0M -103.6M -177.4M
Net income from continuing op. 5.8M -78.0M -108.2M -181.0M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 3 hours 37 minutes

00:23
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).